Date and Time
April 22, 2021 at 2:30-3:30 PM ET and 6:30-7:30 PM ET
- Articulate the pathogenic mechanisms involved in anemia associated with CKD, including the roles of inflammation, hepcidin, and the HIF pathway
- Interpret outcomes from clinical trials evaluating the use of HIF-PHIs to treat anemia in patients with CKD
- Discuss the potential place of HIF-PHIs in the management of anemia in patients with CKD
Dr Robert Provenzano MD, FACP, FASN
Robert Provenzano is an Associate Clinical Professor of Medicine at Wayne State University School of Medicine in Detroit Michigan. He has served previously as the Chief of the Division of Nephrology, Hypertension & Transplantation, Director of Nephrology Research, and Director of Acute Dialysis Services at St John Hospital & Medical Center in Detroit, MI., Chief Operating Officer of St Clair Specialty Physicians in Detroit, and the Vice President of Medical Affairs for DaVita Inc. Dr. Provenzano has recently overseen all of the owned & managed practice for DaVita as its CMO for Nephrology Practice Solutions (NPS). Currently he has focused, in a consultant role, on anemia management for CKD and ESRD patients for several Pharmaceutical organizations. Dr Provenzano completed his internship and residency at St John Hospital and Medical Center. His nephrology fellowship was completed at Henry Ford Hospital in Detroit, MI.
|Non-Member||$20.00 + applicable taxes|
*CANNT Technologist Membership Rate has been reduced to $40.00 for 2021 on the condition Technologist Members participate in a focus group meeting with CANNT to review Technologist’s member benefits. Not a Member? Join now!